Radiotherapy Machines

Radiotherapy Machines Market Outlook

The global radiotherapy machines market was valued at approximately USD 5.5 billion in 2023 and is projected to reach around USD 10.5 billion by 2035, growing at a compound annual growth rate (CAGR) of about 7% during the forecast period from 2025 to 2035. This significant growth can be attributed to the increasing prevalence of cancer worldwide, advancements in radiotherapy technologies, and the rising demand for effective cancer treatment solutions. Additionally, the growing number of healthcare facilities incorporating advanced radiotherapy machines into their treatment protocols is further driving market expansion. Furthermore, increased government and private investments in oncology research and treatment infrastructure are poised to enhance the market landscape in the coming years.

Growth Factor of the Market

The growth of the radiotherapy machines market is primarily driven by the alarming rise in cancer cases globally, which has necessitated the need for efficient treatment options. According to the World Health Organization, cancer is expected to account for approximately 10 million deaths globally by 2025, underscoring the urgency for advanced radiotherapy solutions. Additionally, technological advancements in radiotherapy equipment, such as precision targeting and improved imaging techniques, have made treatments more effective and less invasive, thereby enhancing patient outcomes. The increasing acceptance of radiotherapy as a primary treatment modality, particularly for localized tumors, also contributes to market growth. Moreover, as healthcare systems evolve to adopt patient-centric approaches, the demand for personalized treatment plans—which can be effectively managed with advanced radiotherapy machines—will further bolster the market. Lastly, the rise in funding and support for cancer research initiatives by both public and private sectors is expected to create lucrative opportunities for manufacturers and healthcare providers.

Key Highlights of the Market

• The global radiotherapy machines market is projected to grow at a CAGR of 7% from 2025 to 2035.
• Technological advancements are enhancing the precision and effectiveness of radiotherapy treatments.
• The increasing prevalence of cancer worldwide is driving the demand for radiotherapy machines.
• Government and private sector investments in cancer treatment infrastructure are on the rise.
• Emerging markets are expected to see significant growth in the adoption of radiotherapy technologies.

By Product Type

Linear Accelerators:

Linear accelerators are one of the most widely used radiotherapy machines due to their high efficiency and precision in delivering targeted radiation to cancerous tissues. These machines utilize high-energy beams, usually in the form of photons or electrons, to treat various types of cancers. Linear accelerators can be used in both external beam and IMRT (Intensity-Modulated Radiation Therapy) applications, allowing oncologists to tailor treatment plans according to the specific needs of each patient. The growing preference for non-invasive treatment options, along with the continuous technological improvements in linear accelerators, such as enhanced imaging capabilities and real-time tracking systems, is driving their market share. Furthermore, the development of compact and portable linear accelerators is expanding their accessibility, especially in regions with limited healthcare infrastructure.

Cobalt-60 Machines:

Cobalt-60 machines have been a cornerstone in radiotherapy since their introduction and continue to play a vital role, particularly in developing countries due to their cost-effectiveness. These machines utilize a radioactive source of cobalt-60 to produce gamma rays that target tumors. While they are less sophisticated than linear accelerators, cobalt-60 machines offer reliable performance and can effectively treat various cancers. Despite the advent of more advanced technologies, the demand for cobalt-60 machines remains significant, especially in regions where access to newer technologies is limited. The relatively low operational costs, simplicity in design, and ease of maintenance make them an attractive option for healthcare facilities looking to provide radiotherapy services without incurring significant expenses.

Proton Therapy Machines:

Proton therapy machines represent a cutting-edge advancement in the field of radiotherapy, delivering proton beams that can precisely target tumors while minimizing damage to surrounding healthy tissues. This technology is particularly beneficial for treating pediatric patients and tumors located near critical structures, such as the brain and spinal cord. As research continues to demonstrate the effectiveness of proton therapy in improving patient outcomes, the demand for these specialized machines is on the rise. Although the high cost of proton therapy systems can be a barrier to adoption, the increasing establishment of proton therapy centers worldwide is expected to drive market growth. Additionally, ongoing advancements in proton therapy technology, such as compact systems and improved patient positioning, are enhancing accessibility and expanding treatment options for oncologists.

CyberKnife:

The CyberKnife system is an innovative robotic stereotactic radiosurgery system that allows for non-invasive treatment of tumors anywhere in the body. This technology combines advanced imaging capabilities with a robotic arm to deliver high doses of radiation precisely to the tumor while sparing surrounding healthy tissue. The versatility of the CyberKnife system makes it suitable for treating a wide range of malignancies, including brain tumors, prostate cancer, and lung tumors. With its ability to track tumor movement in real-time, this technology minimizes the need for traditional invasive surgery and can be particularly effective for patients who are not candidates for conventional surgery. As more healthcare providers recognize the benefits of robotic-assisted radiotherapy, the CyberKnife system is gaining traction in the market, driven by its proven efficacy and patient-focused design.

TomoTherapy:

TomoTherapy is a unique treatment modality that combines computed tomography (CT) imaging with radiation therapy, allowing for precise dose delivery to tumors. This technology enables clinicians to visualize the tumor and surrounding anatomy in three dimensions, facilitating more accurate treatment planning. TomoTherapy is particularly effective for complex cases, including those involving irregularly shaped tumors or those located near critical structures. As the demand for personalized radiotherapy continues to rise, TomoTherapy's ability to deliver adaptive treatment plans is becoming increasingly valuable. The integration of advanced imaging and treatment delivery in TomoTherapy machines is poised to enhance patient outcomes and drive market growth, as more healthcare facilities seek comprehensive solutions for cancer treatment.

By Application

External Beam Radiotherapy:

External beam radiotherapy (EBRT) is the most common form of radiotherapy, wherein radiation is delivered from outside the body using machines such as linear accelerators. EBRT is primarily used to treat various solid tumors, including cancers of the breast, prostate, lung, and brain. The ability to deliver high doses of targeted radiation while minimizing exposure to surrounding healthy tissues makes EBRT a popular choice among oncologists. Advances in imaging techniques and treatment planning systems have further improved the precision of EBRT, leading to better treatment outcomes and reduced side effects. As the global cancer incidence rises, the demand for external beam radiotherapy is expected to grow significantly, making it a crucial segment in the radiotherapy machines market.

Internal Beam Radiotherapy:

Internal beam radiotherapy, also known as brachytherapy, involves the placement of radioactive sources directly inside or near the tumor. This method allows for a high dose of radiation to be delivered directly to the cancerous cells while sparing surrounding healthy tissues. Brachytherapy is commonly used in treating cancers of the prostate, cervical, and breast, among others. The major advantage of internal beam radiotherapy lies in its ability to deliver targeted treatment with minimal side effects, which is particularly beneficial for sensitive areas of the body. As advancements in brachytherapy technology continue to evolve, such as the development of new radioactive sources and delivery techniques, the application of internal beam radiotherapy is expected to grow, driving demand for specialized radiotherapy machines.

Systemic Radiation Therapy:

Systemic radiation therapy involves administering radioactive substances, such as iodine-131 or radium-223, through the bloodstream to target cancerous cells throughout the body. This method is particularly effective for treating cancers that have spread or metastasized, such as thyroid cancer and bone metastases. While systemic radiation therapy is less common than external and internal beam radiotherapy, its unique approach provides valuable treatment options for specific cancer types. The increasing understanding of the biological mechanisms behind cancer and the development of targeted radioactive therapies are expanding the applications of systemic radiation therapy. As more healthcare providers recognize the benefits of systemic therapies, the demand for associated radiotherapy machines and delivery systems is anticipated to rise.

By End User

Hospitals:

Hospitals constitute a significant portion of the end-users in the radiotherapy machines market, as they are often the primary healthcare facilities providing cancer treatment services. The integration of advanced radiotherapy technology within hospitals allows for comprehensive cancer care, enabling oncologists to deliver personalized treatment plans that cater to individual patient needs. As hospitals continue to invest in state-of-the-art radiotherapy machines, they are enhancing their capabilities to treat a larger number of patients with diverse cancer types. The growing demand for cancer treatment services, coupled with increasing patient volumes, is driving the expansion of radiotherapy facilities within hospitals. Furthermore, partnerships between hospitals and manufacturers are fostering innovations in treatment delivery and improving patient outcomes.

Cancer Treatment Centers:

Cancer treatment centers specialize in providing comprehensive care for cancer patients, making them critical end-users of radiotherapy machines. These facilities focus on advanced treatment modalities, including surgical interventions, chemotherapy, and radiotherapy, thereby creating a holistic approach to cancer care. The increasing number of dedicated cancer treatment centers worldwide is driven by the rising prevalence of cancer and the need for specialized treatment options. Such centers typically maintain a diverse portfolio of radiotherapy technologies, enabling them to offer tailored treatment plans that align with the specific requirements of each patient. As patients seek high-quality, specialized care, the reliance on cancer treatment centers for effective radiotherapy solutions is likely to grow.

Research Institutes:

Research institutes play a pivotal role in the radiotherapy machines market by conducting clinical trials, developing new treatment methodologies, and advancing radiotherapy technologies. These facilities collaborate with healthcare providers and manufacturers to drive innovations and establish evidence-based practices in cancer treatment. The growing emphasis on research and the development of novel radiotherapy techniques, such as targeted therapies and immunotherapies, is fostering partnerships between research institutes and manufacturers of radiotherapy machines. As the demand for advanced cancer treatment options escalates, research institutes are expected to become increasingly important players in the market, driving the adoption of innovative radiotherapy solutions and enhancing overall patient care.

By Technology

Intensity-Modulated Radiation Therapy:

Intensity-Modulated Radiation Therapy (IMRT) is an advanced form of radiotherapy that allows for precise control over the intensity of radiation beams delivered to the tumor. This technique enables oncologists to tailor the radiation dose, reducing exposure to healthy tissues and minimizing side effects associated with treatment. IMRT is particularly beneficial for treating complex tumors located near critical structures, such as the spinal cord or major organs. As the demand for personalized cancer treatment continues to rise, IMRT is increasingly being incorporated into treatment protocols. The ongoing development of advanced treatment planning systems and imaging technologies further enhances the effectiveness and accessibility of IMRT, driving its prominence within the radiotherapy machines market.

Image-Guided Radiation Therapy:

Image-Guided Radiation Therapy (IGRT) utilizes imaging technologies to improve the precision and accuracy of radiotherapy treatments. By incorporating real-time imaging techniques, such as CT or MRI, IGRT allows oncologists to visualize the tumor's position before and during treatment, ensuring accurate dose delivery. This technology is particularly advantageous for tumors that may change position or shape during the treatment course, such as those in the abdomen or pelvis. As healthcare providers increasingly recognize the importance of accuracy in radiotherapy, the adoption of IGRT is expected to rise significantly. Furthermore, advancements in imaging technologies and the integration of IGRT with other treatment modalities are poised to enhance its effectiveness and contribute to market growth.

Stereotactic Radiotherapy:

Stereotactic radiotherapy is a highly precise treatment modality that delivers high doses of radiation to localized tumors while minimizing damage to surrounding healthy tissues. This technique can be applied in both Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT), making it versatile for treating various cancers, including brain tumors and lung cancers. The ability to deliver focused radiation with high precision has made stereotactic radiotherapy a preferred choice for patients who are not suitable candidates for traditional surgery. As advancements in imaging and tracking technologies continue to evolve, the effectiveness and safety of stereotactic radiotherapy are expected to improve, driving its adoption across healthcare facilities and enhancing its share in the radiotherapy machines market.

By Region

The North American region dominates the global radiotherapy machines market, accounting for approximately 35% of the total market share in 2023. The presence of well-established healthcare infrastructure, high adoption rates of advanced radiotherapy technologies, and significant investment in cancer research contribute to this dominance. In addition, an increasing number of cancer treatment centers and hospitals offering state-of-the-art radiotherapy services further solidifies North America's position as a leader in the market. The region is projected to maintain a healthy growth rate of around 6.5% CAGR during the forecast period, driven by the increasing prevalence of cancer, a growing geriatric population, and advancements in treatment methodologies.

Europe holds the second largest market share, accounting for approximately 30% of the global market in 2023. Factors such as the growing number of cancer cases, advancements in healthcare technologies, and increased funding for cancer research significantly influence market growth in this region. The European market is expected to witness a CAGR of about 7.2% through 2035, driven by the rising demand for personalized treatment options and the increasing establishment of specialized cancer treatment centers. The Asia Pacific region is emerging as a lucrative market for radiotherapy machines, with a significant focus on expanding healthcare infrastructure and improving access to cancer treatment options, contributing to its projected growth in the upcoming years.

Opportunities

The radiotherapy machines market is poised to experience substantial growth opportunities, particularly in emerging markets. As countries in Asia, Latin America, and the Middle East continue to develop their healthcare systems, there is an increasing emphasis on enhancing cancer care services. The rising prevalence of cancer in these regions, combined with a growing awareness of the importance of early detection and treatment, presents a significant opportunity for manufacturers of radiotherapy machines. By establishing partnerships with local healthcare providers and investing in training programs for medical professionals, companies can effectively penetrate these markets and expand their customer base. Additionally, the introduction of cost-effective radiotherapy solutions tailored to the unique needs of these regions will further enhance market opportunities.

Another promising opportunity for growth lies in the ongoing advancements in technology and treatment modalities. The integration of artificial intelligence and machine learning into treatment planning and delivery systems is revolutionizing the radiotherapy landscape. These technologies enable more precise targeting of tumors, improving treatment outcomes and minimizing side effects. Furthermore, the development of personalized treatment plans based on patient-specific factors, such as tumor genetics and pathology, is becoming increasingly prevalent. As healthcare providers recognize the benefits of adopting advanced technologies in radiotherapy, the demand for innovative machines and systems is expected to rise, creating lucrative opportunities for manufacturers to stay competitive in the evolving market landscape.

Threats

Despite the promising growth prospects, the radiotherapy machines market faces several threats that could hinder its expansion. One significant challenge is the high cost associated with advanced radiotherapy technologies, which can limit accessibility for patients and healthcare providers, particularly in low-income regions. The initial capital investment required for state-of-the-art radiotherapy machines can deter smaller hospitals and clinics from adopting these technologies, leading to disparities in cancer care. Moreover, the complexity of these machines necessitates specialized training for medical personnel, further increasing operational costs. If not addressed, these barriers could impede market growth and limit the overall reach of advanced radiotherapy solutions.

Additionally, the rapid pace of technological advancements poses a threat to existing market players. The continuous evolution of radiotherapy technologies may result in shorter product life cycles, forcing manufacturers to invest heavily in research and development to remain competitive. This can lead to increased pressure on profit margins, particularly for companies that struggle to keep up with innovations in the market. Furthermore, the entry of new players with disruptive technologies may intensify competition and challenge established companies. To mitigate these threats, industry stakeholders must focus on fostering collaboration and innovation to adapt to the changing market dynamics effectively.

Competitor Outlook

• Varian Medical Systems
• Siemens Healthineers
• Philips Healthcare
• GE Healthcare
• Accuray Incorporated
• RaySearch Laboratories
• Brainlab AG
• Sumitomo Heavy Industries
• Hitachi, Ltd.
• Isoray, Inc.
• Civco Medical Solutions
• ViewRay, Inc.
• OncoOne, Inc.
• Hologic Inc.
• Neutron Therapeutics, Inc.

The competitive landscape of the radiotherapy machines market is characterized by the presence of several key players, each striving to gain a foothold in this rapidly evolving sector. Companies such as Varian Medical Systems and Siemens Healthineers are leading the way with their innovative technologies and comprehensive portfolios of radiotherapy products. Varian, known for its advanced linear accelerators and treatment planning systems, continues to set industry standards in precision oncology. Siemens Healthineers, with its extensive experience in medical imaging and radiotherapy, is leveraging its technological capabilities to enhance treatment delivery and improve patient outcomes. Both companies are actively investing in research and development to introduce next-generation radiotherapy solutions that meet the growing demands of healthcare providers and patients alike.

Another significant player in the market, Accuray Incorporated, is recognized for its advancements in robotic radiosurgery systems, particularly the CyberKnife. By focusing on non-invasive treatment options and real-time tracking technologies, Accuray has carved a niche in the stereotactic radiotherapy segment. The company’s commitment to innovation and patient care has positioned it as a formidable competitor in the market. Additionally, emerging companies such as ViewRay, Inc. are gaining traction with their unique offerings, including MRIdian, an MRI-guided radiation therapy system that enhances treatment precision and safety. As these companies continue to innovate and expand their product lines, the competitive dynamics within the radiotherapy machines market are expected to intensify.

Furthermore, international players like Philips Healthcare and GE Healthcare are also making significant strides in the radiotherapy market. Philips is leveraging its expertise in imaging technologies to enhance treatment planning and delivery, while GE Healthcare focuses on developing integrated solutions that improve patient care and operational efficiency. The collaboration between these major players and smaller innovative companies is likely to foster advancements in radiotherapy technologies, driving market growth and improving patient outcomes. As the industry evolves, companies that prioritize innovation, collaboration, and customer-centric approaches will be better positioned to succeed in the competitive landscape of radiotherapy machines.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Brainlab AG
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Hologic Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Isoray, Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 GE Healthcare
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Hitachi, Ltd.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 OncoOne, Inc.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 ViewRay, Inc.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Philips Healthcare
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Accuray Incorporated
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Siemens Healthineers
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 RaySearch Laboratories
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Varian Medical Systems
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Civco Medical Solutions
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Sumitomo Heavy Industries
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Neutron Therapeutics, Inc.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Radiotherapy Machines Market, By End User
    • 6.1.1 Hospitals
    • 6.1.2 Cancer Treatment Centers
    • 6.1.3 Research Institutes
  • 6.2 Radiotherapy Machines Market, By Technology
    • 6.2.1 Intensity-Modulated Radiation Therapy
    • 6.2.2 Image-Guided Radiation Therapy
    • 6.2.3 Stereotactic Radiotherapy
  • 6.3 Radiotherapy Machines Market, By Application
    • 6.3.1 External Beam Radiotherapy
    • 6.3.2 Internal Beam Radiotherapy
    • 6.3.3 Systemic Radiation Therapy
  • 6.4 Radiotherapy Machines Market, By Product Type
    • 6.4.1 Linear Accelerators
    • 6.4.2 Cobalt-60 Machines
    • 6.4.3 Proton Therapy Machines
    • 6.4.4 CyberKnife
    • 6.4.5 TomoTherapy

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Radiotherapy Machines Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Radiotherapy Machines market is categorized based on

By Product Type

• Linear Accelerators
• Cobalt-60 Machines
• Proton Therapy Machines
• CyberKnife
• TomoTherapy

By Application

• External Beam Radiotherapy
• Internal Beam Radiotherapy
• Systemic Radiation Therapy

By End User

• Hospitals
• Cancer Treatment Centers
• Research Institutes

By Technology

• Intensity-Modulated Radiation Therapy
• Image-Guided Radiation Therapy
• Stereotactic Radiotherapy

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Varian Medical Systems
• Siemens Healthineers
• Philips Healthcare
• GE Healthcare
• Accuray Incorporated
• RaySearch Laboratories
• Brainlab AG
• Sumitomo Heavy Industries
• Hitachi, Ltd.
• Isoray, Inc.
• Civco Medical Solutions
• ViewRay, Inc.
• OncoOne, Inc.
• Hologic Inc.
• Neutron Therapeutics, Inc.